Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM)

CUSIP: 05464T104

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
48,932,355
Total 13F shares
6,167,172
Share change
-141,118
Total reported value
$41,627,505
Price per share
$6.75
Number of holders
41
Value change
-$969,516
Number of buys
21
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 05464T104?
CUSIP 05464T104 identifies AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2016

As of 31 Dec 2016, Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,167,172 shares. The largest 10 holders included FMR LLC, JPMORGAN CHASE & CO, STIFEL FINANCIAL CORP, BlackRock Fund Advisors, VANGUARD GROUP INC, Lombard Odier Asset Management (USA) Corp, STATE STREET CORP, Allianz Asset Management GmbH, NORTHERN TRUST CORP, and MILLENNIUM MANAGEMENT LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.